Stories this photo appears in:
Alzheimer’s drug Leqembi has FDA approval now
That means Medicare will pay for it
U.S. officials granted full approval to a closely watched Alzheimer’s drug in late June, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing disease.
